[Gastric ulcer and duodenal ulcer (excluding Zollinger-Ellison syndrome). Epidemiology, physiopathology, diagnosis, course, treatment].
Bigard
M A
MA
Service d'hépato-gastro-entérologie, CHU de Nancy, Vandoeuvre-lès-Nancy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000209:etiology* / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D016481:Helicobacter Infections / Q000175:diagnosis / Q000628:therapy; D016480:Helicobacter pylori; D006801:Humans; D013276:Stomach Ulcer / Q000175:diagnosis / Q000209:etiology* / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D015043:Zollinger-Ellison Syndrome / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents